Paraganglioma as a risk factor for bone metastasis-Reference-Cited by-同舟云学术

Paraganglioma as a risk factor for bone metastasis

Published:2018 Issue:3 Volume:65 Page:253-260
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Yokomoto-Umakoshi Maki¹,Umakoshi Hironobu¹,Tsuiki Mika¹,Ogasawara Tatsuki¹,Hamanaka‑Hiroshima Kaho¹,Tanabe Akiyo²,Tagami Tetsuya¹,Shimatsu Akira¹,Naruse Mitsuhide¹

Affiliation:

1. Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

2. Division of Endocrinology, National Center for Global Health and Medicine, Tokyo, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/65/3/65_EJ17-0368/_pdf

Reference24 articles.

1. 1 Zarnegar R, Kebebew E, Duh QY, Clark OH (2006) Malignant pheochromocytoma. Surg Oncol Clin N Am 15: 555–571.

2. 2 Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, et al. (2016) European society of endocrinology clinical practice guideline for long-term follow-up of patients operated on for a pheochromocytoma or a paraganglioma. Eur J Endocrinol 174: G1–G10.

3. 3 Naruse M & PHEO-J Group. Nation-wide survey and PHEO network for the study of pheochromocytoma/paraganglioma in Japan (PHEO-J) (2011) Endocrine Reviews. 32 Meeting Abstracts: 2–631. The Endocrine Society’s 93^rd annual meeting & expo, abstract No. P2–631.

4. 4 Abdel-Aziz TE, Prete F, Conway G, Gaze M, Bomanji J, et al. (2015) Pheochromocytomas and paragangliomas: a difference in disease behaviour and clinical outcomes. J Surg Oncol 112: 486–491.

5. 5 Choi YM, Sung TY, Kim WG, Lee JJ, Ryu JS, et al. (2015) Clinical course and prognostic factors in patients with malignant pheochromocutoma and paraganglioma: a single institution experience. J Surg Oncol 112: 815–821.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma;European Radiology;2024-04-16

2. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma;Pancreas;2021-04

3. Longest survival by the combination of radiation-therapy and resection in patient with metastatic spinal paragangliomas from primary-neck lesion with succinate dehydrogenase subunit B (SDHB) mutation;Endocrine Journal;2021

4. Surgical treatment of malignant paraganglioma with spinal invasion in a juvenile patient;Medicine;2019-09